These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 30904742)
1. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease. Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy. Zhai Y; Cao X; Liu S; Shen Y Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692 [TBL] [Abstract][Full Text] [Related]
3. Association between lipoprotein-associated phospholipase A2 and 25-hydroxy-vitamin D on early stage diabetic kidney disease in patients with type-2 diabetes mellitus. Zhang Z; Qian X; Sun Z; Cheng C; Gu M Heliyon; 2024 Aug; 10(16):e35635. PubMed ID: 39220926 [TBL] [Abstract][Full Text] [Related]
4. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia. Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223 [TBL] [Abstract][Full Text] [Related]
6. Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease. Hanarz M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Malinowski KP; Gajos G Adv Clin Exp Med; 2024 Jun; 33(6):593-600. PubMed ID: 37747445 [TBL] [Abstract][Full Text] [Related]
7. Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study. Yang Y; Xu P; Liu Y; Chen X; He Y; Feng J Diab Vasc Dis Res; 2021; 18(1):1479164121992524. PubMed ID: 33567895 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes. Seyfarth J; Reinehr T; Hoyer A; Reinauer C; Bächle C; Karges B; Mayatepek E; Roden M; Hofer SE; Wiegand S; Woelfle J; Kiess W; Rosenbauer J; Holl RW; Meissner T J Inherit Metab Dis; 2018 Jan; 41(1):73-79. PubMed ID: 29027597 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection. Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269 [TBL] [Abstract][Full Text] [Related]
10. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135 [TBL] [Abstract][Full Text] [Related]
11. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population. Cai A; Li G; Chen J; Li X; Li L; Zhou Y BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China. Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599 [TBL] [Abstract][Full Text] [Related]
13. Role of vitamin D in risk factors of patients with type 2 diabetes mellitus. Zhang Q; Wu Y; Lu Y; Fei X Med Clin (Barc); 2020 Mar; 154(5):151-156. PubMed ID: 31255367 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population. Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T; Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease. Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715 [TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Lipoprotein-Associated Phospholipase A(2), Cholesteryl Ester Transfer Protein and Lipid Profile and Risk of Atherosclerosis in Women with Iron Deficiency Anaemia. Yang S; Chen XY; Xu XP Clin Lab; 2015; 61(10):1463-9. PubMed ID: 26642708 [TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk]. Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients. Zhang S; Wang J; Chen S; Zhang Y; He R; Wang X; Ding F; Hu W; Dai Y; Lu L; Zhang R; Ni J; Chen Q BMC Cardiovasc Disord; 2024 May; 24(1):251. PubMed ID: 38745157 [TBL] [Abstract][Full Text] [Related]
20. Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population. Yan D; Tu Y; Jiang F; Wang J; Zhang R; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W PLoS One; 2015; 10(6):e0129797. PubMed ID: 26029914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]